A comprehensive evaluation, including quality of life (QOL), mental and emotional status, nutritional condition, daily living, frailty, cognition, general health, and comorbidity status, in patients with malignant intracranial tumors during the peri-surgical period can determine prognosis and guide treatment decisions.
Why this matters
Surgery with radiotherapy and drug therapy remains the most common treatment for malignant intracranial tumors, with the specific regimen tailored to the individual patient.
Several discrete pre- and post-operative assessments are available that can determine the tolerance of an individual patient to surgery, radiotherapy, and pharmacotherapy.
A systematic and comprehensive peri-surgical assessment tool for patients with malignant intracranial tumors is warranted to guide treatment decisions.